Prognostic value of exercise-induced ventricular arrhythmia in Chagas' heart disease

Pacing Clin Electrophysiol. 2011 Nov;34(11):1492-7. doi: 10.1111/j.1540-8159.2011.03171.x.

Abstract

Objective: To determine the prevalence and the prognostic value of exercise-induced ventricular arrhythmia (EIVA) in chronic Chagas' heart disease.

Study design and setting: An open prospective cohort of 130 clinically stable patients at a University Hospital outpatient unit in Rio de Janeiro, Brazil, was followed up at scheduled clinical visits from 1990 through 2007. The endpoint was total cardiovascular mortality. Survival curves (Kaplan-Meier) and a multivariate Cox proportional hazard model were adjusted to determine the association between EIVA and mortality.

Results: The median duration of follow-up was 9.9 years (range, 132 days to 17 years). EIVA prevalence was 43.1% (95% CI: 34.5-51.7). Thirty-three cardiovascular deaths (25.4%) occurred. The hazard ratio of EIVA for cardiovascular death, after adjustment for age, was 1.84 (P = 0.09). An interaction was found between EIVA and cardiomegaly on x-ray. In the group with cardiomegaly, the hazard of dying was four times greater in the presence of EIVA (P for interaction = 0.05).

Conclusion: In clinically stable chagasic subjects with cardiomegaly, EIVA is a clinically significant marker of total cardiovascular mortality and may be a useful risk stratification tool in this population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brazil / epidemiology
  • Cardiomyopathies
  • Chagas Disease / diagnosis*
  • Chagas Disease / mortality*
  • Comorbidity
  • Electrocardiography / statistics & numerical data*
  • Exercise Test / statistics & numerical data*
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Prognosis
  • Reproducibility of Results
  • Risk Assessment
  • Risk Factors
  • Sensitivity and Specificity
  • Survival Analysis
  • Survival Rate
  • Tachycardia, Ventricular / diagnosis*
  • Tachycardia, Ventricular / mortality*